TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/24 18:20 | 3/7/24 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Namouni Fouad | MA | O | P,R,D | S | -397 | 90.69 | 0 | -4 | -6 | 73 | D | ||||||||||||||
10/5/23 10:47 | 10/4/23 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Namouni Fouad | MA | O | P,R,D | S | -181 | 48.06 | 0 | -4 | -6 | 62 | D | ||||||||||||||
3/8/23 21:34 | 3/6/23 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Namouni Fouad | MA | O | P,R,D | S | -89 | 45.68 | 0 | -2 | -3 | 66 | D | ||||||||||||||
10/5/22 18:54 | 10/4/22 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Namouni Fouad | MA | O | P,R,D | S | -234 | 67.30 | 0 | -3 | -6 | 53 | D | ||||||||||||||
3/8/22 16:06 | 3/7/22 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Namouni Fouad | MA | O | P,R,D | S | -59 | 56.19 | 0 | -1 | -2 | 56 | D | ||||||||||||||
10/7/21 16:26 | 10/5/21 | BPMC | Blueprint Medicines Corp | DE | Health | Drug | Pharmaceutical Preparations | Namouni Fouad | MA | O | P,R,D | S | -318 | 98.18 | 0 | -3 | -7 | 42 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |